vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and Frontdoor, Inc. (FTDR). Click either name above to swap in a different company.
Frontdoor, Inc. is the larger business by last-quarter revenue ($451.0M vs $270.4M, roughly 1.7× Enhabit, Inc.). Frontdoor, Inc. runs the higher net margin — 9.1% vs -14.3%, a 23.4% gap on every dollar of revenue. On growth, Frontdoor, Inc. posted the faster year-over-year revenue change (5.9% vs 4.7%). Frontdoor, Inc. produced more free cash flow last quarter ($114.0M vs $3.3M). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -8.8%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Frontdoor, Inc. operates a leading U.S.-focused home services and protection platform. It offers customizable home warranty plans covering repairs and replacements for household appliances, HVAC, plumbing, and electrical systems, plus on-demand access to a network of pre-vetted local service professionals for residential maintenance and repairs.
EHAB vs FTDR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $451.0M |
| Net Profit | $-38.7M | $41.0M |
| Gross Margin | — | 55.0% |
| Operating Margin | -12.3% | — |
| Net Margin | -14.3% | 9.1% |
| Revenue YoY | 4.7% | 5.9% |
| Net Profit YoY | 15.9% | 10.8% |
| EPS (diluted) | $-0.76 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $451.0M | ||
| Q4 25 | $270.4M | $432.0M | ||
| Q3 25 | $263.6M | $618.0M | ||
| Q2 25 | $266.1M | $617.0M | ||
| Q1 25 | $259.9M | $426.0M | ||
| Q4 24 | $258.2M | $383.0M | ||
| Q3 24 | $253.6M | $540.0M | ||
| Q2 24 | $260.6M | $542.0M |
| Q1 26 | — | $41.0M | ||
| Q4 25 | $-38.7M | $1.0M | ||
| Q3 25 | $11.1M | $106.0M | ||
| Q2 25 | $5.2M | $111.0M | ||
| Q1 25 | $17.8M | $37.0M | ||
| Q4 24 | $-46.0M | $9.0M | ||
| Q3 24 | $-110.2M | $100.0M | ||
| Q2 24 | $-200.0K | $92.0M |
| Q1 26 | — | 55.0% | ||
| Q4 25 | — | 49.3% | ||
| Q3 25 | — | 57.1% | ||
| Q2 25 | — | 57.7% | ||
| Q1 25 | — | 55.2% | ||
| Q4 24 | — | 48.0% | ||
| Q3 24 | — | 56.7% | ||
| Q2 24 | — | 56.5% |
| Q1 26 | — | — | ||
| Q4 25 | -12.3% | 0.5% | ||
| Q3 25 | 6.4% | 23.0% | ||
| Q2 25 | 6.3% | 23.7% | ||
| Q1 25 | 6.1% | 11.3% | ||
| Q4 24 | -16.0% | 1.6% | ||
| Q3 24 | -38.6% | 24.8% | ||
| Q2 24 | 4.3% | 22.9% |
| Q1 26 | — | 9.1% | ||
| Q4 25 | -14.3% | 0.2% | ||
| Q3 25 | 4.2% | 17.2% | ||
| Q2 25 | 2.0% | 18.0% | ||
| Q1 25 | 6.8% | 8.7% | ||
| Q4 24 | -17.8% | 2.3% | ||
| Q3 24 | -43.5% | 18.5% | ||
| Q2 24 | -0.1% | 17.0% |
| Q1 26 | — | $0.57 | ||
| Q4 25 | $-0.76 | $0.03 | ||
| Q3 25 | $0.22 | $1.42 | ||
| Q2 25 | $0.10 | $1.48 | ||
| Q1 25 | $0.35 | $0.49 | ||
| Q4 24 | $-0.92 | $0.10 | ||
| Q3 24 | $-2.20 | $1.30 | ||
| Q2 24 | $0.00 | $1.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $603.0M |
| Total DebtLower is stronger | $426.0M | $1.2B |
| Stockholders' EquityBook value | $534.0M | $230.0M |
| Total Assets | $1.2B | $2.2B |
| Debt / EquityLower = less leverage | 0.80× | 5.07× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $603.0M | ||
| Q4 25 | $43.6M | $566.0M | ||
| Q3 25 | $56.9M | $563.0M | ||
| Q2 25 | $37.1M | $562.0M | ||
| Q1 25 | $39.5M | $506.0M | ||
| Q4 24 | $28.4M | $436.0M | ||
| Q3 24 | $45.7M | $375.0M | ||
| Q2 24 | $28.5M | $419.0M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $426.0M | $1.1B | ||
| Q3 25 | $441.5M | $1.2B | ||
| Q2 25 | $456.9M | $1.2B | ||
| Q1 25 | $467.3M | $1.2B | ||
| Q4 24 | $492.6M | $1.2B | ||
| Q3 24 | $502.9M | $565.0M | ||
| Q2 24 | $512.7M | $569.0M |
| Q1 26 | — | $230.0M | ||
| Q4 25 | $534.0M | $242.0M | ||
| Q3 25 | $566.8M | $316.0M | ||
| Q2 25 | $552.4M | $254.0M | ||
| Q1 25 | $543.2M | $198.0M | ||
| Q4 24 | $523.5M | $239.0M | ||
| Q3 24 | $566.1M | $261.0M | ||
| Q2 24 | $674.3M | $214.0M |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $1.2B | $2.2B | ||
| Q2 25 | $1.2B | $2.2B | ||
| Q1 25 | $1.2B | $2.1B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.4B | $1.2B |
| Q1 26 | — | 5.07× | ||
| Q4 25 | 0.80× | 4.73× | ||
| Q3 25 | 0.78× | 3.64× | ||
| Q2 25 | 0.83× | 4.56× | ||
| Q1 25 | 0.86× | 5.88× | ||
| Q4 24 | 0.94× | 4.90× | ||
| Q3 24 | 0.89× | 2.16× | ||
| Q2 24 | 0.76× | 2.66× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | — |
| Free Cash FlowOCF − Capex | $3.3M | $114.0M |
| FCF MarginFCF / Revenue | 1.2% | 25.3% |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $387.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.4M | $101.0M | ||
| Q3 25 | $37.8M | $64.0M | ||
| Q2 25 | $10.6M | $127.0M | ||
| Q1 25 | $17.9M | $124.0M | ||
| Q4 24 | $-4.1M | $58.0M | ||
| Q3 24 | $28.4M | $25.0M | ||
| Q2 24 | $9.6M | $103.0M |
| Q1 26 | — | $114.0M | ||
| Q4 25 | $3.3M | $95.0M | ||
| Q3 25 | $36.2M | $58.0M | ||
| Q2 25 | $8.7M | $120.0M | ||
| Q1 25 | $17.6M | $117.0M | ||
| Q4 24 | $-4.7M | $50.0M | ||
| Q3 24 | $27.7M | $16.0M | ||
| Q2 24 | $8.9M | $91.0M |
| Q1 26 | — | 25.3% | ||
| Q4 25 | 1.2% | 22.0% | ||
| Q3 25 | 13.7% | 9.4% | ||
| Q2 25 | 3.3% | 19.4% | ||
| Q1 25 | 6.8% | 27.5% | ||
| Q4 24 | -1.8% | 13.1% | ||
| Q3 24 | 10.9% | 3.0% | ||
| Q2 24 | 3.4% | 16.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 1.4% | ||
| Q3 25 | 0.6% | 1.0% | ||
| Q2 25 | 0.7% | 1.1% | ||
| Q1 25 | 0.1% | 1.6% | ||
| Q4 24 | 0.2% | 2.1% | ||
| Q3 24 | 0.3% | 1.7% | ||
| Q2 24 | 0.3% | 2.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 101.00× | ||
| Q3 25 | 3.41× | 0.60× | ||
| Q2 25 | 2.04× | 1.14× | ||
| Q1 25 | 1.01× | 3.35× | ||
| Q4 24 | — | 6.44× | ||
| Q3 24 | — | 0.25× | ||
| Q2 24 | — | 1.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
FTDR
Segment breakdown not available.
